Lecturer NATO School and NATO Joint CBRN-defense Centre of Excellence
Visiting lecturer CBRN University of Rome Tor Vergata
Research University of Groningen, Netherland
Message to our Participants, Distinguished Speakers, and Scholars for Attending
Biotechnology and Biomaterials Science experts! Have an innovative idea to
share? Join us for our Global Summit and
Expo on Biotechnology and Biomaterials Science (GSBBS2024) Conference
chaired by Prof. Stef Stienstra, and
be part of the change. At this event, you’ll have the opportunity to network
with the brightest minds in the field, discuss and develop new strategies and
influence Biotechnology and Biomaterials, discusses the latest research
innovations and important developments in this field.
your voice with us and help shape the future of Biotechnology and Biomaterials
Science. Click the link to register
for this exclusive event today! #GSBBS2024 #Biotechnology and Biomaterials
are fortunate to be among the pioneers of this exciting and rapidly changing
field. The technological achievements are the result of dedication, and
year, the organizers have assembled a series of plenary, keynote and invited
presentations from distinguished members of the international will share with
us their world class scientific R&D. We are looking forward to your
presentation among these inventors.
Prof. Dr. Stef Stienstra
Chairman GSBBS2024, Apex Global Meetings
Research University in Groningen, Netherlands
Biochemistry: The branch of science that explores the chemical processes within and related to living organisms.
Bioethics: Ethical considerations related to biotechnology and its applications.
Bioinformatics: The use of computer science and mathematics to analyze biological data.
Bioinformatics: The use of computer technology to analyze and manage biological data.
Biological Diversity: The variety of life forms on Earth, including biodiversity conservation.
Biology: The science of life and living organisms.
Biomedical Research: Research focused on understanding health and disease.
Biopharmaceuticals: Medicines produced using biotechnology, including vaccines and gene therapies.
Biophysics: Applying physics principles to understand biological processes.
Bioprocessing: Techniques for large-scale production of biological products, such as fermentation.
Bioremediation: Using living organisms to clean up environmental pollutants.
Biotechnology: The use of living organisms or their systems to develop or make useful products.
Cell Biology: The study of cells, the basic structural and functional units of life.
Cloning: Creating genetically identical copies of an organism or gene.
CRISPR-Cas9: A revolutionary gene-editing tool in biotechnology.
Ecology: The study of the relationships between organisms and their environments.
Epidemiology: The study of the distribution and causes of diseases in populations.
Evolution: The process by which species change over time.
Fermentation: A process used to produce biofuels, enzymes, and other bioproducts.
Gene Editing: Precise modification of an organism
Genetically Modified Organisms (GMOs): Organisms with altered DNA for specific traits.
Genetic Engineering: The manipulation of an organism
Genetics: The study of genes and heredity.
Genome Sequencing: Determining the complete DNA sequence of an organism
Genomics: The study of an organism
Immunology: The study of the immune system and its response to pathogens.
Microbiology: The study of microscopic organisms like bacteria, viruses, and fungi.
Molecular Biology: The study of biological molecules and their roles in cellular processes.
Neuroscience: The study of the nervous system, including the brain and nerves.
Pharmacogenomics: Studying how genes influence an individual
Pharmacology: The study of drugs and their effects on living organisms.
Proteomics: The study of all proteins produced by an organism.
Proteomics: The study of proteins, their structures, functions, and interactions.
Recombinant DNA: DNA formed by combining genes from different sources, often used in biotechnology.
Stem Cells: Cells with the potential to develop into different cell types in the body.
Synthetic Biology: Designing and constructing biological parts, devices, and systems.
Tissue Engineering: Creating functional tissues or organs in the lab for transplantation.
Transgenic Organisms: Organisms that contain genes from other species.
Virology: The study of viruses and viral diseases.
Drug Design and Development
Biomedical Engineering and Instrumentation
Stem Cell Biology
Applications of Stem Cells
Applications of Stem Cells
Applications of Stem Cells
According to estimates, the global biotechnology
market would grow from USD 129.14 billion in 2021 to USD 151.10 billion in
2022, with a CAGR of 17.0%. By 2026, the biotech industry is projected to grow
at a CAGR of 15.3% and reach USD 267.29 billion. With a 15.83% CAGR, the
biotechnology market will be worth $2.44 trillion by 2028. With annual income
growth rates of 10-15%, the global bioeconomy may be worth more than $20
trillion by 2030. Between 2021 and 2028, market growth is anticipated for the
biotechnology sector. Growing incidence of chronic diseases necessitates the
use of cutting-edge biotechnology tools and products, which propels the
biotechnology market's expansion. Due to the rise in prevalence, the
biotechnology market is expanding.
The estimated value of the worldwide biotechnology
market was USD 793.87 billion in 2021 and is projected to reach USD 1,683.52
billion by 2030, growing at a notable CAGR of 8.7% from 2022 to 2030. The
market is being driven by supportive government initiatives as a result of the
expansion of the biotechnology sector in developing countries like China,
Japan, and India.
During the forecast period, the growth of the
biotechnology market will be fueled by factors such as the increasing
prevalence of target diseases and genetic engineering, ongoing technological
advancements in Polymerase Chain Reaction (PCR) technologies, the creation of
portable instruments that are smaller and incorporate robotics, as well as
increased investments in, funding for, and grants for research activities.
Fermentation, nanobiotechnology, tissue engineering,
bioinformatics, chromatography, PCR technology, cell-based assays, and DNA
sequencing technology are the biotechnology industries with the biggest market
value. With a 17.0% CAGR, the pharmaceutical filtering market is anticipated to
reach $29.7 billion by 2027. With a CAGR of 11.4%, the market for DNA
sequencing is predicted to be worth USD 11.2 billion. According to estimates,
the market for 3D cell culture would grow at a 15.6% CAGR from $1.3 billion in
2022 to $2.6 billion in 2027. The market for protein characterization and
identification is anticipated to grow at a CAGR of 13.7% to $23.9 billion by
2026. According to estimates, the market for bioprocessing will grow at a CAGR
of 20.5% from $8.2 billion in 2021 to $20.8 billion by 2026. By 2027, the
market for plasma fractionation is projected to reach $36.7 billion, growing at
a CAGR of 6.7%. By 2027, the market for cell biology and analysis is projected
to reach $28.6 billion with a CAGR of 10.1%. The market for the human genomics
and microbiome is anticipated to grow at a CAGR of 31.1% from $269 million in
2023 to $1,370 million in 2029.
During the anticipated period, the biotechnology
market will be dominated by the biopharmaceutical sector. Based on technology,
the nano-biotechnology category led the market in 2021 with the greatest market
share, and from 2022 to 2030, it had a CAGR of almost 17%. On the other hand,
bioinformatics is anticipated to expand quickly during the projected period, at
a rate of 21.5%.
Above analysis revealed three elements that draw
investors to the European biotechnology market: significant hotspots across
geographies, therapeutic modalities, and industry; formidable research and
industrial capabilities to support basic science and innovation; and an
abundance of top personnel. Europe has a complicated biotech ecosystem, with
hundreds of businesses, numerous avenues for research and financing, and
obvious regional variations.